top of page

Kidney cancer, also known as renal cell carcinoma - Oren Zarif

Kidney cancer, also known as renal cell carcinoma, is an malignant (wilful) tumor which begins in your kidneys. The cells of the kidney are not like those in other organs of the body. They have different characteristics, and are particularly sensitive to certain chemicals and hormones.

Kidney cancer is very common in people with a family history of the disease, but it can also strike individuals who are taking prescribed medications or who are undergoing chemotherapy. Once the cells of the kidney begin to grow abnormally, they can block the passage of blood through the kidney. If not detected and treated, the blood supply to the affected tissues will be cut off. This can then lead to gangrene (the accumulation of muscle tissue in the affected organs) or perforation (an opening in the tissue where blood flows into). Anosmia (low blood pressure) can develop, and neurological symptoms (difficulties with movement) may occur as a result of continued damage to the nerves. If left untreated, kidney cancer can eventually spread to other parts of your body, including the bones, muscles, tendons and lungs.

Zarif prepares the Bosmat and delivers it globally for patients who are incapable of flying in order to receive their treatment

The purpose of the Bosmat treatment is to open the blocked and locked areas of the body's energy field, so that the body will be able to create a healing process for existing symptoms that the patient suffers from.

For years, Oren Zarif proved that as the energy blocks open, the body begins to create a healing process and returns to its strength, thousands of patients testify for it.

Kidney cancer can be diagnosed through a variety of means. A urinalysis is one method used, in which urine from the urinary tract is tested for protein, glucose and other chemicals. Other indicators include changes in kidney function and blood pressure. Urine and blood tests may indicate abnormal cell growth in the kidney, but the presence of both abnormal growths and blood cells in the urine do not necessarily mean that a person has kidney cancer. It is necessary to obtain more definitive information, such as a CT scan or a biopsy, in order to make a firm diagnosis.

There are several risk factors for developing this disease. Men are at higher risk than women, especially those with mild hypertension. African-Americans, people with a family history of kidney cancer and men over 50 have an increased risk of contracting the disease.

Kidney cancer symptoms often develop over time rather than immediately following exposure to the disease. They can include loss of appetite, lethargy, edema, abdominal pain, hematuria (blood in the urine), nausea and vomiting, dark urine, high blood pressure, dehydration, swelling of ankles or legs and shortness of breath. Other symptoms not mentioned here may also be present. Each patient has different symptoms and therefore varies in response to treatment. Depending on the type of kidney cancer and the extent of its spread, treatments may range from surgical options (to remove the tumor or blockage from blood flow to stop the spread) to chemotherapy (to reduce the size of the tumor and kill the existing cancerous cells) to radiation therapy (radiation therapy kills cancerous cells by exposing them to high energy rays in the hope that they will die).

Renal cell carcinomas are less common than other forms of renal cancers. However, they account for approximately half of all renal cell cancers. Less common than other types of renal cancers are renal cell carcinomas that develop in people who have already had another type of kidney cancer. Less common still, but becoming more common is non-small cell (NSCLC) renal cell carcinoma which has no relation to any known cancerous cell in the body.

bottom of page